Table 4.
Malignancy | Trial Name | NCT Number | Patients | Study Arm | Control Arm | Primary Outcome |
---|---|---|---|---|---|---|
CRC | POACC-1 | 03700411 | Undergoing open radical surgery for CRC | Morphine | N/A | Change in CTCs count following surgery depending on the type of perioperative analgesia |
Piritramid | ||||||
Epidural | ||||||
Breast | HER2Cell | 04993014 | Early HER2+ breast cancer w/complete response to neoadjuvant trastuzumab and pertuzumab | Adjuvant trastuzumab | N/A | DFS between adjuvant arms based on whether the patient had HER2 + CTCs at baseline analysis |
Adjuvant trastuzumab plus pertuzumab | N/A | |||||
Liver | N/A | 04800497 | Resected HCC | N/A | N/A | Association between CTCs obtained 0, 30, 90, 180, and 365 days following surgical resection and DFS |
Breast | N/A | 03928210 | Advanced or metastatic breast cancer | Digoxin | N/A | Change in CTCs cluster size after ingestion of oral digoxin |
Breast | N/A | 04065321 | Luminal A breast cancer w/o lymph node involvement | CTCs monitoring | PET-CT examination | DFS |
Prostate | C-ProMeta-1 | 05533515 | Localized prostate cancer scheduled for robot-assisted prostatectomy | CTCs level prior to surgery and at 3 months post-surgery | N/A | Post-radical prostatectomy treatment failure during 4.5 years of follow-up |
Thoracic malignancy | N/A | 04048512 | Neoplastic thoracic disease undergoing resection with intraoperative ECMO or CPB | CTCs quantification | N/A | Quantification of CTCs before and after surgery |
Neoplastic thoracic disease undergoing resection without ECMO or CPB | ||||||
Pancreas | EUS-CTCs | 04677244 | Suspected pancreas cancer | CTCs detection in portal venous blood before and after endoscopic biopsy | N/A | Frequency of increase of CTCs > 4cells/mL in portal system after endoscopic biopsy |
Bladder | N/A | 04811846 | Recurrent transitional cell cancer of the bladder | Transurethral resection of bladder tumor | N/A | Change of CTC count in blood before, during, and after the procedure, and CTC number and characterization in purging fluid |
Plasma kinetic vaporization of bladder tumor | ||||||
Stomach | N/A | 05208372 | Gastric cancer | Radical laparotomy | N/A | Quantity and classification of CTCs in ascites and blood and expression of ctDNA in ascites and blood |
Laparoscope-assisted radical gastrectomy |
Abbreviations: CRC: colorectal cancer, CTCs: circulating tumor cell, DFS: disease-free survival, ECMO: extracorporeal membrane oxygenation, CPB: cardiopulmonary bypass.